Overview

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

Status:
Unknown status

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Conelations With Voiding Diary, King's Health Quentionaire, Overactive Bladder Sympton Scores and Patient Perception of Bladder Condition.

Phase:

N/A

Details

Lead Sponsor:

National Taiwan University Hospital

Treatments:

Muscarinic Antagonists
Solifenacin Succinate